HIV-1 Evolution and Immune Response
Author Information
Author(s): Zabrina L. Brumme, Chanson J. Brumme, David Heckerman, Bette T. Korber, Marcus Daniels, Jonathan Carlson, Carl Kadie, Tanmoy Bhattacharya, Celia Chui, James Szinger, Theresa Mo, Robert S. Hogg, Julio S. G. Montaner, Nicole Frahm, Christian Brander, Bruce D. Walker, P. Richard Harrigan
Primary Institution: Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
Hypothesis
The study investigates how HLA class I influences the evolution of HIV-1 through immune selection.
Conclusion
The study found that HLA class I-mediated selection significantly impacts HIV-1 evolution, particularly in the Nef gene, and correlates with disease progression.
Supporting Evidence
- The study identified 478 unique HLA-associated polymorphisms across HIV genes.
- Nef exhibited a significantly higher density of HLA-associated polymorphisms compared to other genes.
- A significant inverse correlation was found between HLA-associated polymorphisms and CD4+ T cell count.
Takeaway
HIV can change to avoid being recognized by the immune system, and understanding this can help in making better vaccines.
Methodology
The study used a viral lineage-corrected analytical method to analyze HLA class I-associated polymorphisms in HIV genes from a large cohort of chronically infected individuals.
Potential Biases
The cohort may be biased towards individuals with more rapid disease progression due to being referred for treatment.
Limitations
The study is cross-sectional and may not establish cause and effect; it also relies on a single CD4+ cell measurement.
Participant Demographics
The study included 765 HIV-infected, antiretroviral-naïve adults from British Columbia, Canada.
Statistical Information
P-Value
p = 0.006
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website